June 1, 2026: More Than 125 Lawsuits Join GLP-1 MDL as Eli Lilly Asks for Dismissal of Plaintiffs Experts With the GLP-1 MDL reaching 3,763 total cases as of June 1, Eli Lilly, the manufacturer of Ozempic, has requested that the judge dismiss the plaintiffs experts
GLP-1 is an FDA-approved weight loss treatment for managing adult weight
A lab-informed approach to weight loss Comprehensive lab testing may provide valuable insights into factors influencing weight management, energy levels, metabolism, and overall wellness
Summary: Ozempic does not directly affect the menstrual cycle, but the significant weight loss it causes can indirectly disrupt reproductive hormones, leading to irregular periods, changes in bleeding patterns, or temporary amenorrhoea
Compounded oral formulations typically cost $150 to $400 per month versus $200 to $600 for compounded injectables
Can I still qualify